Enliven Therapeutics, Inc. (ELVN)
Market Closed
17 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
53. 20
+2.34
+4.6009%
$
3.7B Market Cap
- P/E Ratio
- Div Yield
818,000 Volume
-2.36 Eps
$ 50.86
Previous Close 
Want to track ELVN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Enliven Therapeutics, Inc. (ELVN) Statistics
Valuation metrics
Market Cap 3.7B
Enterprise value 3.67B
Trailing P/E (ttm) -32.44
Forward P/E -
PEG ratio -2.18
Price/Sales (ttm) -
Price/Book (mrq) 7.37
Enterprise Value/Revenue -
Enterprise Value/EBITDA -37.22
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 742.95K
Average volume (90 days) 1.21M
Price summary
52-Week low 14.79
52-Week high 54.1
Beta -
50-Day moving average 47.51
200-Day moving average 33.81
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:4
Last split Date 24 Feb 2023
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.21%
Return on equity -0.21%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.57
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 7.2
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 40.32%
Book value per share (mrq) 7.22
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
